Transdermal Delivery System Manufacturer | Active Transport Components (OEM)
Engineering active transdermal delivery systems? Our iontophoresis electrodes utilize electro-repulsion for controlled charge transfer. High-efficiency Ag/AgCl design minimizes competitive ion migration for targeted local concentration.
Technology Overview
Precision Engineering for Non-Invasive Delivery.
TOP-RANK Iontophoresis Electrodes serve as the critical Active Transport Interface within a transdermal drug delivery system. Unlike passive diffusion vectors, this component utilizes a controlled electrical gradient to actively drive ionic solutions across the stratum corneum barrier.
This system is engineered to achieve high local concentration within the target tissue zone (e.g., synovial fluid or subcutaneous structure) while significantly reducing systemic exposure compared to oral or hypodermic administration.
The Physics of Electro-Repulsion
1. Ionic Charge Driving Force The core mechanism relies on Electro-Repulsion: like charges repel.
- Cathodic Transport: For negatively charged molecules (e.g., Dexamethasone Sodium Phosphate), the electrode interface exerts a repulsive force, driving the ions away from the surface and into the tissue.
- Anodic Transport: For positively charged molecules (e.g., Lidocaine HCl), the polarity is reversed to initiate transport.
2. Ag/AgCl: Controlled Charge Transfer To maximize transport efficiency, the electrode interface must minimize energy loss.
- Competitive Ion Suppression: We utilize a highly stabilized Ag/AgCl (Silver/Silver Chloride) element. This material prevents the hydrolysis of water at the interface.
- Result: The electrical current is utilized almost exclusively for drug ion migration, rather than transporting unwanted competitive ions (H+ or OH-), ensuring predictable flux rates.
Engineering Comparison: Active vs. Passive
The following engineering-level comparison highlights the distinction between iontophoretic transport and passive patches.
| Parameter | TOP-RANK Active Transport Interface | Passive Transdermal Patch |
| Driving Force | External Electrical Potential (Electro-Repulsion) | Concentration Gradient (Diffusion) |
| Transport Rate | High Flux (Controlled by Current) | Low Flux (Limited by Barrier) |
| Depth Profile | Deep Tissue Penetration | Superficial / Systemic Absorption |
| Dosage Control | Precise (mA-min calculation) | Variable / Time-Dependent |
Formulation-Specific Optimization (OEM)
Partnering for Molecule-Specific Delivery.
We collaborate with pharmaceutical partners and medical device developers to optimize the electrode interface for specific drug formulations. This is not simple "private labeling"; it is component engineering.
- Molecule Size Adaptation: Customizing the reservoir pore structure to accommodate specific molecular weights.
- Ionic Behavior Matching: Tuning the conductive element surface area to match the required current density for your specific ionic solution.
- Feasibility Validation: Providing small-batch prototypes for clinical evaluation and permeation studies.
System Compatibility
Interface Type
Universal Lead Wire Connection.
Current Capacity
Designed for 0 – 4.0 mA delivery protocols.
Dosage Capacity
Compatible with standard 40 – 80 mA-min controllers.
Component Class
Single-Use Delivery Vector (Ag/AgCl).
Technical Inquiry CTA
Engineer Your Delivery System
Discuss the feasibility of active transdermal transport for your formulation. Contact our engineering team for technical documentation and component specifications.
Hot Tags: iontophoresis electrode for transdermal drug delivery, China iontophoresis electrode for transdermal drug delivery manufacturers, suppliers, factory, dexamethasone for iontophoresis patch, iomed patch, ionto pads, iontophoresis cortisone patch, Iontophoresis Pad, Iontophoresis Patches
